Advanced Enzyme Technologies Ltd
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 7.82Advanced Enzyme Technologies demonstrates a financially sound position, particularly in solvency and growth, reflecting a stable capital structure and strong expansion. Profitability and liquidity are also robust, indicating effective management and operational efficiency. However, the company shows some inefficiencies in asset utilization. While the growth rates are impressive, the company needs to maintain these trajectories to capitalize on market opportunities. Overall, Advanced Enzyme Technologies exhibits a solid financial profile, poised for continued success if it can address its efficiency metrics and sustain its growth momentum.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsHighly Overvalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio6.40
- Profitability Ratio10.00
- Efficiency Ratio3.33
- Coverage Ratio10.00
- Solvency Ratio10.00
- Liquidity Ratio8.78
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursBullish
- 4 HoursBullish
- 1 DayBullish
- 1 WeekBullish
- 1 MonthBullish
Health Score : 7.82Advanced Enzyme Technologies demonstrates a financially sound position, particularly in solvency and growth, reflecting a stable capital structure and strong expansion. Profitability and liquidity are also robust, indicating effective management and operational efficiency. However, the company shows some inefficiencies in asset utilization. While the growth rates are impressive, the company needs to maintain these trajectories to capitalize on market opportunities. Overall, Advanced Enzyme Technologies exhibits a solid financial profile, poised for continued success if it can address its efficiency metrics and sustain its growth momentum.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
31.72
Industry Median
6.37
Small Cap Median
6.37
P/E RATIO
24.78
P/B RATIO
2.56
Industry Median
1.36
Small Cap Median
1.36
P/S RATIO
5.77
Industry Median
4.77
Small Cap Median
4.77
Others
PEG RATIO
8.60
EV/EBITDA RATIO
15.24
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹373.4 as on Jun 18, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤9th May 26
Statement Of Audited Consolidated Financial Results For The Quarter And Year Ended 31 March 20
UNDEFINED SENTIMENT
Quarterly Report⬤31st Jan 26
Quarterly Financial Results Q3 FY 2025-26
BULLISH SENTIMENT
Growth Score : 10.00The company has demonstrated strong growth across various metrics, including revenue, operating profit, EPS, assets, and net income. This indicates a robust expansion trajectory and effective management strategies. Sustaining this growth will be critical for future success.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 5.38 | 2.27 | 15.34 | 2.08 | 17.11 |
| Operating Profit Growth Rate | -12.5 | -22.17 | 30.38 | -4.85 | 16.84 |
| Earnings Per Share (EPS) Growth | -18.26 | -11.68 | 26.14 | -1.68 | 28.58 |
| Asset Growth Rate | 9.95 | 11.98 | 7.8 | 5.92 | 14.15 |
| Net Income Growth Rate | -17.88 | -16.13 | 31.73 | -2.19 | 29.85 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Financial Score : 6.40The company's financial metrics suggest that it is generating reasonable earnings per share and has a decent book value. The company makes investments without spending much. However, there is room to improve cash earnings per share. Overall, the company's financial health is satisfactory.
Adjusted Earnings Per Share (Adjusted EPS)AverageCash Earnings Per Share (Cash EPS)WeakBook Value Per ShareAverageDividend Per Share (DPS)AverageCapital Expenditures (CapEx)Excellent| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 11.55 | 9.55 | 13.82 | 12.45 | 15.55 |
| Cash Earnings Per Share (Cash EPS) | 14.45 | 12.64 | 15.64 | 15.55 | 19.45 |
| Book Value Per Share | 98.91 | 112.27 | 120.36 | 129.09 | 148.36 |
| Dividend Per Share (DPS) | 0.96 | 1.04 | 5.13 | 5.16 | 1.36 |
| Capital Expenditures (CapEx) | 27 | 38 | 47 | 34 | 52 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Profitability Score : 10.00The company has demonstrated excellent profitability, with strong margins and returns on capital, equity, and assets. This indicates effective operational management and efficient use of resources. Maintaining these profitability levels will support long-term financial health and growth.
Gross Profit MarginExcellentReturn on Capital Employed (ROCE)ExcellentReturn on Equity (ROE)ExcellentReturn on Assets (ROA)ExcellentOperating MarginExcellentNet MarginExcellent| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.76 | 22.74 | 27.4 | 24.96 | 25.34 |
| Return on Capital Employed (ROCE) | 16 | 12 | 15 | 13 | 14 |
| Return on Equity (ROE) | 11.4 | 8.42 | 10.35 | 9.44 | 10.66 |
| Return on Assets (ROA) | 16.11 | 11.2 | 13.54 | 12.17 | 12.45 |
| Operating Margin | 38.37 | 29.21 | 33.01 | 30.77 | 30.7 |
| Net Margin | 23.44 | 19.22 | 21.96 | 21.04 | 23.32 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
Efficiency Score : 3.33The company's asset turnover ratios suggest that it is not efficiently utilizing its assets to generate revenue. The company needs to improve how it uses its assets to boost sales. This could be due to various factors such as slow-moving inventory or inefficient capital deployment.
Fixed Asset Turnover RatioPoorInventory Turnover RatioWeakReceivables Turnover RatioAverageDays Sales in Inventory RatioPoorReceivable DaysWeakCapital Turnover RatioPoor| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 0.85 | 0.83 | 0.96 | 0.94 | 1.08 |
| Inventory Turnover Ratio | 3.37 | 3.4 | 3.33 | 3.13 | 3.34 |
| Receivables Turnover Ratio | 6.08 | 5.76 | 6.27 | 5.95 | 5.74 |
| Days Sales in Inventory Ratio | 108.31 | 107.35 | 109.61 | 116.61 | 109.28 |
| Receivable Days | 60.03 | 63.37 | 58.21 | 61.34 | 63.59 |
| Capital Turnover Ratio | 0.47 | 0.43 | 0.46 | 0.44 | 0.45 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
Coverage Score : 10.00The company has strong coverage ratios, indicating that it can comfortably meet its interest and dividend obligations. High-interest coverage suggests a low risk of defaulting on debt payments. This provides financial stability and security for investors.
Interest Coverage RatioExcellentEquity Dividend Coverage RatioExcellent| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 58 | 47.67 | 48 | 38.4 | 78.67 |
| Equity Dividend Coverage Ratio | 11.11 | 9.09 | 2.33 | 2.27 | 11.11 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
Solvency Score : 10.00The company's capital structure is very stable, with minimal debt relative to equity and assets. This indicates a low risk of financial distress and a strong equity base. The company can comfortably meet its long-term obligations. Low leverage provides the company with financial flexibility.
Debt RatioExcellentDebt to Equity RatioExcellentEquity RatioExcellentDebt To Asset RatioExcellent| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
| Debt to Equity Ratio | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
| Equity Ratio | 0.97 | 0.98 | 0.98 | 0.98 | 0.99 |
| Debt To Asset Ratio | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
Liquidity Score : 8.78The company has a strong ability to meet its short-term obligations. High current and quick ratios indicate a comfortable cushion to cover immediate liabilities. However, the operating cash flow ratio suggests there might be some challenges in converting sales into cash, which could impact day-to-day operations.
Current RatioExcellentQuick RatioExcellent
Cash RatioGoodOperating Cash Flow RatioAverage| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 3.75 | 2.58 | 2.54 | 2.63 | 2.72 |
| Quick Ratio | 2.88 | 1.74 | 1.66 | 1.67 | 1.78 |
| Cash Ratio | 1.96 | 0.83 | 0.76 | 0.66 | 0.62 |
| Operating Cash Flow Ratio | 0.87 | 0.95 | 0.84 | 0.87 | 0.84 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Advanced Enzyme Technologies Ltd | 7.82 | 24.78 | Highly Overvalued | 229.00 | 11.77 | 174.00 |
| 2 | Panacea Biotec Ltd | 5.61 | -607.78 | Neutral | -5.00 | -4.88 | -7.00 |
Balanced ManagementAdvanced Enzyme Technologies' management demonstrates a mixed performance. Consistent sales growth, reflected in compounded sales growth rates, is a positive indicator. However, profit growth has been inconsistent, as shown by fluctuations in compounded profit growth. The decline in promoter holding raises concerns about long-term commitment. Overall, the company exhibits financial strengths but also areas requiring improvement and vigilance, leading to an 'Orange' rating.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Compounded Sales Growth (TTM) | 2.09% | Demonstrates consistent revenue expansion. |
| Dividend Yield | 1.48 % | Good | |
| CONS | Compounded Profit Growth (TTM) | -2.19% | Profitability growth has slowed. |
| Promoter Holding | 43.08% | Decrease in promoter holding raises concerns. |
Financial Performance & GrowthAverageCapital Efficiency & ReturnsAverageFinancial Health & PrudenceGoodShareholding & Ownership StructureAverageFinancial Performance & Growth
Advanced Enzyme Technologies shows fluctuating financial performance. Sales have increased steadily, but profit growth has been inconsistent. Compounded Sales Growth indicates consistent revenue expansion, but Compounded Profit Growth rates have varied significantly.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Compounded Sales Growth (%) | 17.79% | 12.84% | 5.02% | 2.13% | 15.39% | 2.09% |
| Compounded Profit Growth (%) | 20.01% | 5.31% | -3.59% | -13.46% | 31.73% | -2.19% |
Recent quarterly results reveal fluctuating OPM %, showing operational efficiency is not consistently maintained. The YOY Profit Growth % has also been unstable, further highlighting the inconsistency in financial performance.
Capital Efficiency & Returns
Capital efficiency and returns for Advanced Enzyme Technologies present a mixed view. ROCE and ROE have fluctuated, indicating variability in the returns generated from capital employed and shareholder funds.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| ROCE % | 24% | 22% | 22% | 15% | 12% | 15% | 13% |
ROCE % has decreased from 24% in Mar 2019 to 13% in Mar 2025, indicating a decline in the efficiency of capital utilization. ROE % also displays a similar trend, reflecting lower returns on shareholder equity.
Financial Health & Prudence
The financial health and prudence of Advanced Enzyme Technologies appear generally stable. The company maintains a relatively low debt-to-equity ratio, suggesting controlled leverage.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debt/Equity Ratio | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 |
The dividend payout ratio has increased significantly in recent years.
Shareholding & Ownership Structure
The shareholding and ownership structure of Advanced Enzyme Technologies indicates some potential concerns. The promoter holding has decreased.
| Metric | Mar 2017 | Mar 2019 | Mar 2021 | Mar 2023 | Mar 2025 |
|---|---|---|---|---|---|
| Promoter Holding (%) | 70.10% | 57.31% | 55.38% | 49.88% | 43.08% |
Balanced RiskThe risk assessment for Advanced Enzyme Technologies is rated as 'Orange,' indicating moderate risk. Segment performance volatility is a concern, given fluctuations in quarterly results. The foreign exchange and interest rate exposure could pose challenges, considering global market dynamics.
Segment performance volatilityAverageForeign exchange or interest rate exposureAverageRegulatory compliance cost trendsAverageSegment performance volatility
Segment performance for Advanced Enzyme Technologies exhibits volatility, as evidenced by fluctuations in quarterly sales and profit growth. The YOY Sales Growth % and YOY Profit Growth % show considerable variation across different quarters.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| YOY Sales Growth (%) | 5.30% | 21.60% | 13.81% | 13.25% | 13.78% | 5.93% |
| YOY Profit Growth (%) | 43.31% | 63.88% | 31.29% | 49.66% | 8.23% | -30.12% |
Foreign exchange or interest rate exposure
Advanced Enzyme Technologies is exposed to foreign exchange and interest rate risks. Fluctuations in exchange rates and interest rates can impact the company's earnings and financial stability.
Regulatory compliance cost trends
The cost of regulatory compliance for Advanced Enzyme Technologies may be an increasing risk factor. Evolving regulations in the healthcare sector could lead to higher compliance expenses.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10371.77Bullish
- SMA 20370.52Bullish
- SMA 50368.60Bullish
- EMA 10371.61Bullish
- EMA 20370.81Bullish
- EMA 50370.27Bullish
- DEMA 10372.41Bearish
- DEMA 20372.02Bearish
- DEMA 50369.73Bullish
- TEMA 10372.37Bearish
- TEMA 20372.72Bearish
- TEMA 50370.75Bullish
- MACD0.94Bullish
- ADX18.11Weak Trend
- IndicatorValueSignal
- RSI54.11Neutral
- CCI19.04Neutral
- ROC 90.76Bullish
- ROC 14-0.09Bearish
- ROC 251.85Bullish
- Stoch K69.43Neutral
- Stoch D65.98Neutral
- IndicatorValueSignal
- BB Upper375.31Neutral
- BB Middle370.52Neutral
- BB Lower365.73Neutral
- ATR3.61High Volatility
- IndicatorValueSignal
- MFI42.88Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10371.49Bullish
- SMA 20369.94Bullish
- SMA 50371.06Bullish
- EMA 10371.35Bullish
- EMA 20370.57Bullish
- EMA 50370.91Bullish
- DEMA 10372.52Bearish
- DEMA 20371.13Bullish
- DEMA 50370.89Bullish
- TEMA 10372.86Bearish
- TEMA 20372.56Bearish
- TEMA 50367.60Bullish
- MACD0.60Bullish
- ADX18.28Weak Trend
- IndicatorValueSignal
- RSI52.55Neutral
- CCI37.03Neutral
- ROC 90.94Bullish
- ROC 141.85Bullish
- ROC 252.58Bullish
- Stoch K77.55Neutral
- Stoch D80.49Overbought
- IndicatorValueSignal
- BB Upper374.95Neutral
- BB Middle369.94Neutral
- BB Lower364.94Neutral
- ATR4.97Low Volatility
- IndicatorValueSignal
- MFI48.58Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10370.15Bullish
- SMA 20369.68Bullish
- SMA 50373.59Bearish
- EMA 10370.83Bullish
- EMA 20370.81Bullish
- EMA 50367.13Bullish
- DEMA 10371.58Bullish
- DEMA 20370.34Bullish
- DEMA 50381.49Bearish
- TEMA 10372.73Bearish
- TEMA 20369.77Bullish
- TEMA 50N/AN/A
- MACD-0.13Bullish
- ADX12.83Weak Trend
- IndicatorValueSignal
- RSI51.50Neutral
- CCI36.69Neutral
- ROC 91.16Bullish
- ROC 140.53Bullish
- ROC 25-2.21Bearish
- Stoch K52.74Neutral
- Stoch D50.79Neutral
- IndicatorValueSignal
- BB Upper376.25Neutral
- BB Middle369.68Neutral
- BB Lower363.11Neutral
- ATR8.04Low Volatility
- IndicatorValueSignal
- MFI62.02Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10369.50Bullish
- SMA 20373.70Bearish
- SMA 50349.69Bullish
- SMA 100318.38Bullish
- SMA 200317.02Bullish
- EMA 10371.07Bullish
- EMA 20369.54Bullish
- EMA 50352.27Bullish
- EMA 100334.01Bullish
- EMA 200324.81Bullish
- DEMA 10370.54Bullish
- DEMA 20376.81Bearish
- DEMA 50379.16Bearish
- DEMA 100355.87Bullish
- DEMA 200327.89Bullish
- TEMA 10369.78Bullish
- TEMA 20369.76Bullish
- TEMA 50388.78Bearish
- TEMA 100376.44Bearish
- TEMA 200344.51Bullish
- MACD4.45Bearish
- ADX32.45Strong Trend
- IndicatorValueSignal
- RSI55.04Neutral
- CCI-31.42Neutral
- ROC 142.58Bullish
- ROC 251.48Bullish
- Stoch K35.98Neutral
- Stoch D31.29Neutral
- IndicatorValueSignal
- BB Upper387.82Neutral
- BB Middle373.71Neutral
- BB Lower359.59Neutral
- ATR14.35Low Volatility
- IndicatorValueSignal
- MFI71.95Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20315.36Bullish
- SMA 50315.90Bullish
- EMA 20329.52Bullish
- EMA 50321.00Bullish
- DEMA 20349.58Bullish
- DEMA 50317.29Bullish
- TEMA 20368.09Bullish
- TEMA 50327.63Bullish
- MACD17.54Bullish
- ADX29.42Strong Trend
- IndicatorValueSignal
- RSI60.66Neutral
- CCI152.56Overbought
- ROC 1424.08Bullish
- ROC 2519.54Bullish
- Stoch K68.67Neutral
- Stoch D69.28Neutral
- IndicatorValueSignal
- BB Upper390.53Neutral
- BB Middle315.36Neutral
- BB Lower240.19Neutral
- ATR28.84Low Volatility
- IndicatorValueSignal
- MFI75.91Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6311.06Bullish
- SMA 12319.16Bullish
- SMA 24343.26Bullish
- EMA 6324.09Bullish
- EMA 12321.60Bullish
- EMA 24327.23Bullish
- DEMA 6334.99Bullish
- DEMA 12316.59Bullish
- DEMA 24321.72Bullish
- TEMA 6348.47Bullish
- TEMA 12323.02Bullish
- TEMA 24309.10Bullish
- MACD5.18Bearish
- ADX14.36Weak Trend
- IndicatorValueSignal
- RSI52.64Neutral
- CCI77.42Neutral
- ROC 25-7.87Bearish
- ROC 5029.03Bullish
- Stoch K18.81Oversold
- Stoch D29.87Neutral
- IndicatorValueSignal
- BB Upper418.25Neutral
- BB Middle324.50Neutral
- BB Lower230.75Neutral
- ATR60.47High Volatility
- IndicatorValueSignal
- MFI55.16Neutral